Jobs
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.
We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
GRAIL is headquartered in the bay area of California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies.
For more information, please visit grail.com
The Customer Service Coordinator (CSC) serves as the primary point of contact when a customer interacts with GRAIL via phone, email, and chat. In addition to being responsible for receiving inbound communications from customers within GRAIL’s virtual contact center environment, the CSC demonstrates a firm understanding of the importance of exceptional service within the realm of cancer care.
The CSC is committed to personal and professional change and growth, meeting the needs of the customer and the company, and making a true difference in a caller’s day and within the healthcare landscape as a whole.
This role is based in Menlo Park, California, and will move to Sunnyvale, California, in Fall 2026. It offers a flexible work arrangement, with the ability to work from GRAIL's office or from home. Our current flexible work arrangement policy requires that a minimum of 40%, or 16 hours, of your total work week be on-site. Your specific schedule, determined in collaboration with your manager, will align with team and business needs and could exceed the 40% requirement for the site. At our Menlo Park campus, Tuesdays and Thursdays are the key days where we encourage on-site presence to engage in events and on-site activities.
Total Views
0
Apply Clicks
0
Weekly mock applicants
0
Bookmarks
0
Similar jobs

Overnight Seasonal Customer Service Agent – O’Hare Airport
Enterprise · Chicago, IL

Male Receptionist / Spa Attendant (Part-Time) - Hilton Waikoloa Village
Hilton · Waikoloa, Hawaii, United States

Bilingual Customer Service Specialist (Spanish)
Sherwin-Williams · Forest, VA, United States, US

Customer Service Specialist
Sherwin-Williams · Catskill, NY, United States, US

Customer Service Coordinator
Penske · Norton, MA, United States, US
About Grail

Grail
Series CGRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
201-500
Employees
Menlo Park
Headquarters
$3.2B
Valuation
Reviews
3.9
10 reviews
Work-life balance
3.8
Compensation
3.5
Culture
4.2
Career
3.0
Management
3.2
72%
Recommend to a friend
Pros
Good work-life balance
Supportive team and management
Innovative and challenging projects
Cons
Heavy workload and overwhelming at times
Limited career advancement opportunities
Management and communication issues
Salary Ranges
135 data points
Senior/L5
Senior/L5 · Senior Analytical Engineer
3 reports
$187,544
total per year
Base
$163,039
Stock
-
Bonus
-
$180,790
$195,500
Interview experience
4 interviews
Difficulty
2.8
/ 5
Duration
14-28 weeks
Experience
Positive 25%
Neutral 75%
Negative 0%
Interview process
1
Application Review
2
Recruiter Screen
3
Technical Phone Screen
4
Onsite/Virtual Interviews
5
Team Matching
6
Offer
Common questions
Technical Knowledge
Behavioral/STAR
Past Experience
Coding/Algorithm
News & Buzz
GRAIL (NASDAQ: GRAL) outlines CEO transition, director elections in 2026 proxy - Stock Titan
Stock Titan
News
·
4d ago
My Grail Everyday Watch Gets the Perfect Summer Revamp - Gear Patrol
Gear Patrol
News
·
4d ago
Lilly's $2.25B bet chases genetic medicine's 'holy grail' - FirstWord Pharma
FirstWord Pharma
News
·
4d ago
Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’ - BioSpace
BioSpace
News
·
4d ago